WHEN & WHERE:
- June 16, 2016
- Fundación INSIMED
- Bogota, Colombia
Call Us: +1 305 560 5337
NATIONAL SYMPOSIUM OF STEM CELLS 2016
Symposium participants received a comprehensive review of cellular medicine, review current techniques, and learn various applications and protocols for delivering stem cell treatments to patients that address a range of health and aesthetic indications.
The field of regenerative medicine is expanding at an exponential rate. The number of clinical trials employing adult stem cells is now in the thousands.
BQ, Duncan Ross
DOCTOR
08:00 - 09:00
Exosomes as an aid in cell therapy management.
PhD in Immunology from the University of Miami.
Founder: Kimera Labs- Manipulation and storage of stem cells derived from adipose tissue for cosmetic surgery procedures. Outpatient Center Dr. Carlos Spera M.D., Davie, Florida.
Dr. Joseph Purita
DOCTOR
09:00 - 10:00
Musculoskeletal and antiaging applications of Stem Cells.
Orthopedic surgeon from Georgetown University Medical School.
Pioneer in the use of stem cells and PRP therapies for orthopedic diseases.
Specialist in the treatment of high-performance athletes.
Dr. Enrique Testart
DOCTOR
10:00 - 11:00
Osteogenesis and the future of heterologous implants.
Pediatric surgeon from the University of Chile. He became a specialist in microsurgery in France.
He has developed his own techniques and protocols in Cellular Therapies and in the management of musculoskeletal problems, complementing conventional surgery with regenerative medicine.
Chile Representative for Global Stem Cells Group.
Dr. Rafael Pérez
DOCTOR
11:00 - 12:00
Use of cell therapy in the treatment for alopecia.
Surgeon from the Universidad del Bosque and plastic surgeon by the San Rafael Clinic.
He has been an Instructor for post graduate degree in Plastic Surgery for the Hospital Universitario de San Rafael.He works as a plastic surgeon in private practice.
Dr. Alfredo Hoyos
Plastic Surgeon
12:00 - 13:00
Use of cell therapy in the treatment for alopecia.
In recent years, a number of modalities have become available for the noninvasive reduction of adipose tissue, including cryolipolysis, radiofrequency, low-level laser, and high-intensity focused ultrasound. Each technology employs a different mechanism of action to cause apoptosis or necrosis of the targeted adipocytes.
Among these technologies, cryolipolysis has not only been commercially available for the longest time, but has also been best researched including in vitro and animal models and randomized controlled clinical trials in humans.
The principle behind cryolipolysis exploits the premise that adipocytes are more susceptible to cooling than other skin cells. The precise application of cold temperatures triggers apoptosis of the adipocytes, which invokes an inflammatory response and leads to slow digestion by surrounding macrophages.
Dr. Al Sears MD
DOCTOR
13:00 - 14:00
Determining the Feasibility of Using Stem Cells to Treat Erectile Dysfunction in Humans
Stem cell therapy is thought to improve wound healing and promote vasculogenesis. Erectile Dysfunction (ED) is largely from microvascular disease such as diabetes and hypertension.
This presentation seeks to evaluate the feasibility and effects of intracavernosal injection of Placental Matrix derived Mesenchymal Stem Cells (PM-MSCs) for the treatment of ED.
